teva logo 88.
(photo credit: )
Teva Pharmeceutical Industries said Sunday it expects to close its acquisition of Ivax Corporation by January 12.
Teva agreed to buy Ivax in July for $7.4 billion, the largest ever acquisition by an Israeli company.
The companies said they have signed a consent order for submission to the US Federal Trade Commision (FTC) which is "the last remaining regulatory condition to the consummation of the transaction."
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>